.ai-based software may help predict risk of dementia
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.one woman's migraine story
.
$17
OFF DEAL
OFF DEAL
GET DEAL
218 Used Today
$20
OFF DEAL
OFF DEAL